Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Pharma, Inc.

79.37
-1.0300-1.28%
Post-market: 79.370.00000.00%19:47 EDT
Volume:1.71M
Turnover:135.92M
Market Cap:15.54B
PE:-22.24
High:80.76
Open:79.75
Low:79.33
Close:80.40
52wk High:93.42
52wk Low:47.26
Shares:195.81M
Float Shares:167.00M
Volume Ratio:0.88
T/O Rate:1.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5686
EPS(LYR):-3.7850
ROE:-1789.67%
ROA:-26.00%
PB:-6.18
PE(LYR):-20.97

Loading ...

BridgeBio Pharma Doses First Patient in Trial Evaluating Long-Term Impact of Heart Disease Medicine

MT Newswires Live
·
Yesterday

BridgeBio Pharma doses first patient in ASCEND-ATTR trial

TIPRANKS
·
Yesterday

BridgeBio Announces First Participant Dosed in Ascend-Attr, a Phase 3B/4 Study Evaluating the Long-Term Effects of Acoramidis on Disease Regression in Attr-Cm

THOMSON REUTERS
·
Yesterday

13D Filings

Dow Jones
·
Aug 22

BridgeBio Pharma CEO Neil Kumar Disposes of USD 3.07 Million in Common Shares

Reuters
·
Aug 21

BridgeBio Pharma's Transition to Rare Disease 'Commercial Powerhouse' On Track, RBC Says

MT Newswires Live
·
Aug 14

Analysts Are Bullish on Top Healthcare Stocks: BridgeBio Pharma (BBIO), Pyxis Oncology (PYXS)

TIPRANKS
·
Aug 14

BridgeBio Pharma, - Announces Pricing of 5,000,000 Share Secondary Offering by KKR Genetic Disorder L.p.

THOMSON REUTERS
·
Aug 14

BridgeBio Launches Secondary Offering of 5,000,000 Shares by KKR Genetic Disorder LP

Reuters
·
Aug 14

BridgeBio Pharma Announces Launch of Secondary Offering of Common Stock on Behalf of an Existing Shareholder

THOMSON REUTERS
·
Aug 14

Omeros Q2 Yartemlea Net Revenue Jumps 190%

Reuters
·
Aug 13

BridgeBio Pharma is Maintained at Buy by Truist Securities

Dow Jones
·
Aug 13

Liquidia Q2 Revenue Jumps on Yutrepia Sales

Reuters
·
Aug 12

U.S. Research Roundup-Cardinal Health, Lumentum Holdings, Public Storage

Reuters
·
Aug 12

BridgeBio Oncology Therapeutics Beri Opsi Saham 65.350 Lembar Kepada Dua Karyawan Baru Dengan Harga Pelaksanaan USD 9,28

Reuters
·
Aug 12

Bridgebio Pharma Reports Inducement Grants Under NASDAQ Listing Rule

Reuters
·
Aug 12

BridgeBio Memberi 66.705 Unit Saham Terbatas Kepada 56 Karyawan Baru

Reuters
·
Aug 12

BridgeBio Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 12

BridgeBio Pharma Price Target Raised to $104.00/Share from $101.00 by B of a Securities

Dow Jones
·
Aug 12

BridgeBio Posted Q2 Revenue Beat, but Faces Higher Near-Term Launch Opex, Morgan Stanley Says

MT Newswires Live
·
Aug 11